Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Moleculin Biotech ( (MBRX) ) has issued an update.
Moleculin Biotech, Inc. announced the use of a new corporate presentation on November 18, 2024, which is available on their website. The information, however, is not filed under the Securities Exchange Act or the Securities Act unless specifically noted. This development may interest those tracking Moleculin’s strategic moves and market position.
See more data about MBRX stock on TipRanks’ Stock Analysis page.
